PALO ALTO, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that one late breaking clinical trials oral presentation, one oral presentation, and three poster sessions will be shared at the Heart Failure Society of America (HFSA) Annual Scientific [...]

The ABC Third Annual Policy Pulse Summit will bring together leaders across healthcare, government, industry, advocacy, and community coalitions to advance policy-driven solutions that close gaps in cardiovascular access, treatment, and prevention. This year's agenda will explore challenges such as cardiology deserts, access to evidence-based therapies, and the role of technology and trusted messengers in improving early detection [...]

The Association of Black Cardiologists (ABC) proudly honors one of its visionary Founding Members, Dr. Walter M. Booker, Sr., PhD (1907–1988), whose pioneering work in cardiovascular pharmacology continues to shape how we understand and treat heart disease today. Dr. Booker was a biologist, physiologist and pharmacologist who served for twenty years as the chairman of the Department of [...]

As cardiovascular medicine advances into the digital age, artificial intelligence (AI) is transforming cardiac imaging at an unprecedented pace. This rapidly evolving integration presents both remarkable opportunities and significant challenges that will shape the career trajectories of emerging cardiologists. For cardiology fellows in training (FITs), understanding and adapting to these changes represent a unique professional opportunity. Recent advances [...]